In addition, during the Q4, we entered into new forward sale agreements under our ATM program to sell approximately 800,000 shares, which will generate anticipated gross proceeds of $24,600,000 At year end, we had a total of approximately 1,100,000 shares of common stock subject to outstanding forward sale agreements, which upon settlement are anticipated to raise gross proceeds of approximately $32,200,000 Returning to our $67,000,000 committed investment pipeline, as Chris mentioned, these transactions are fully funded through a combination from our outstanding forward equity agreements and the remaining $75,000,000 available to us under our delayed draw term loan. Pro form a for these investments in capital activity, we expect our balance sheet to remain well positioned to support continued growth. I'd note that since 20 we've acquired more than $1,200,000,000 of new assets, while effectively managing our balance sheet and maintaining leverage near the midpoint of our target range 4.5x to 5.5x net debt to EBITDA. As our investment pipeline evolves, we will continue to evaluate all capital sources to ensure that we're funding transactions in an accretive manner, while continuing to maintain these leverage levels and our investment grade profile. With respect to our environmental liability, we ended the year at $22,400,000 which was a reduction of approximately $800,000 since the end of 2022.